Response Genetics, Inc (RGDXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2015 | 15.86 Million USD | 8.57% |
| 2014 | 14.61 Million USD | 18.83% |
| 2013 | 12.29 Million USD | -28.21% |
| 2012 | 17.13 Million USD | 22.47% |
| 2011 | 13.98 Million USD | 0.8% |
| 2010 | 13.87 Million USD | 36.8% |
| 2009 | 10.14 Million USD | 51.92% |
| 2008 | 6.67 Million USD | -28.27% |
| 2007 | 9.3 Million USD | -32.36% |
| 2006 | 13.76 Million USD | 86.48% |
| 2005 | 7.37 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2015 FY | 15.86 Million USD | 8.57% |
| 2015 Q1 | 15.71 Million USD | 7.53% |
| 2014 FY | 14.61 Million USD | 18.83% |
| 2014 Q1 | 11.92 Million USD | -3.06% |
| 2014 Q2 | 7.2 Million USD | -39.54% |
| 2014 Q3 | 14.25 Million USD | 97.74% |
| 2014 Q4 | 14.61 Million USD | 2.53% |
| 2013 Q1 | 10.89 Million USD | -36.42% |
| 2013 Q4 | 12.29 Million USD | 10.76% |
| 2013 FY | 12.29 Million USD | -28.21% |
| 2013 Q2 | 11.26 Million USD | 3.42% |
| 2013 Q3 | 11.1 Million USD | -1.42% |
| 2012 Q4 | 17.13 Million USD | -31.86% |
| 2012 Q2 | 15.36 Million USD | -5.74% |
| 2012 Q1 | 16.29 Million USD | 16.49% |
| 2012 FY | 17.13 Million USD | 22.47% |
| 2012 Q3 | 25.14 Million USD | 63.69% |
| 2011 FY | 13.98 Million USD | 0.8% |
| 2011 Q4 | 13.98 Million USD | 19.23% |
| 2011 Q3 | 11.73 Million USD | -6.59% |
| 2011 Q2 | 12.55 Million USD | -2.4% |
| 2011 Q1 | 12.86 Million USD | -7.26% |
| 2010 FY | 13.87 Million USD | 36.8% |
| 2010 Q1 | 14.72 Million USD | 45.14% |
| 2010 Q2 | 14.17 Million USD | -3.69% |
| 2010 Q4 | 13.87 Million USD | -2.78% |
| 2010 Q3 | 14.27 Million USD | 0.66% |
| 2009 Q4 | 10.14 Million USD | 50.67% |
| 2009 FY | 10.14 Million USD | 51.92% |
| 2009 Q3 | 6.73 Million USD | 14.08% |
| 2009 Q2 | 5.9 Million USD | -16.81% |
| 2009 Q1 | 7.09 Million USD | 6.25% |
| 2008 Q1 | 8.3 Million USD | -10.74% |
| 2008 Q3 | 6.28 Million USD | -15.56% |
| 2008 Q4 | 6.67 Million USD | 6.25% |
| 2008 Q2 | 7.44 Million USD | -10.43% |
| 2008 FY | 6.67 Million USD | -28.27% |
| 2007 Q4 | 9.3 Million USD | 35.56% |
| 2007 Q2 | 8.81 Million USD | -40.7% |
| 2007 Q1 | 14.85 Million USD | 7.97% |
| 2007 FY | 9.3 Million USD | -32.36% |
| 2007 Q3 | 6.86 Million USD | -22.07% |
| 2006 FY | 13.76 Million USD | 86.48% |
| 2006 Q4 | 13.76 Million USD | 34.32% |
| 2006 Q3 | 10.24 Million USD | 0.0% |
| 2005 FY | 7.37 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -339.773% |
| Arrayit Corporation | 7.49 Million USD | -111.656% |
| Atlantic International Corp. | 3.82 Million USD | -314.432% |
| Biocept, Inc. | 22.01 Million USD | 27.92% |
| Bioqual, Inc. | 18.93 Million USD | 16.216% |
| CardioGenics Holdings Inc | 1.79 Million USD | -783.993% |
| DermTech, Inc. | 64.75 Million USD | 75.497% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 97.841% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -28.105% |
| iMD Companies, Inc. | 1.67 Million USD | -847.727% |
| IDenta Corp. | 1.01 Million USD | -1466.093% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 43.648% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -5225.444% |
| InVitro International | 78.99 Thousand USD | -19987.353% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 19.575% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -12171.746% |
| Medical Imaging Corp. | 9.51 Million USD | -66.721% |
| NovelStem International Corp. | 4.2 Million USD | -277.24% |
| Optigenex Inc. | 9.57 Million USD | -65.789% |
| PharmChem, Inc. | 558.64 Thousand USD | -2740.255% |
| Proteome Sciences plc | 18.48 Million USD | 14.182% |
| Rennova Health, Inc. | 49.66 Million USD | 68.053% |
| RushNet, Inc. | 6.23 Million USD | -154.32% |
| ScreenPro Security Inc. | 1.6 Million USD | -891.324% |
| Stella Diagnostics Inc. | 18 Million USD | 11.876% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -93.406% |
| Todos Medical Ltd. | 50.15 Million USD | 68.365% |